BEUDAMED
    FDA Adverse Event Death Summary report: N

    EUFLEXXA

    MDR report key: 8260547 · Received January 17, 2019

    Report

    Report Number
    MW5083207
    Event Type
    Death
    Date Received
    January 17, 2019
    Report Date
    January 16, 2019
    Manufacturer
    FERRING PHARMACEUTICALS INC.
    Product Code
    MOZ
    UDI-DI
    55566410001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    003

    Narratives

    Description of Event or Problem · 1

    PT'S MED OFFICE REPORTED PT DIED BETWEEN (B)(6) 2019. ARXWP NEVER FILLED EUFLEXXA FOR THE PT. STRENGTH: 10 MG/ML - MILLIGRAMS PER MILLILITRES. DOSE OR AMOUNT: 2 ML MILLILITRE(S); FREQUENCY: WEEKLY FOR 3 WEEKS. ROUTE: INTRA-ARTICULAR. DIAGNOSIS OR REASON FOR USE: UNILATERAL PRIMARY OSTEOARTHRITIS, RIGHT KNEE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    52292 EUFLEXXA ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC. 55566410001

    Patients

    Seq Age Sex Outcome Treatment
    1 Death